NRX Pharmaceuticals Inc (NASDAQ:NRXP) price closed higher on Monday, May 06, jumping 45.71% above its previous close.
A look at the daily price movement shows that the last close reads $2.10. The company’s 5Y monthly beta was ticking 1.03. Taking into account the 52-week price action we note that the stock hit a 52-week high of $12.00 and 52-week low of $1.90. The stock subtracted -42.26% on its value in the past month.
NRX Pharmaceuticals Inc, which has a market valuation of $29.28 million, is expected to release its quarterly earnings report May 14, 2024 – May 20, 2024.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give NRXP a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Buy, while an average of long term indicators are currently assigning the stock as 50% Sell.
The overview shows that NRXP’s price is at present -17.91% off the SMA20 and -31.91% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 43.47, with weekly volatility standing at 29.16%. The indicator jumps to 14.99% when calculated based on the past 30 days. NRX Pharmaceuticals Inc (NASDAQ:NRXP)’s beta value is holding at 1.19, while the average true range (ATR) indicator is currently reading 0.63.
An analysis of the NRX Pharmaceuticals Inc (NASDAQ:NRXP) stock in terms of its daily trading volume indicates that the 3-month average is 250.99K.
Current records show that the company has 8.39M in outstanding shares. The insiders’ percentage holdings are 20.20% of outstanding shares while the percentage share held by institutions stands at 4.20%. But the -33.48% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
